Symptomatic response to Helicobacter pylori eradication in children with recurrent abdominal pain: Double blind randomized placebo-controlled trial

Journal of Clinical Gastroenterology

Volumn 38, Issue 8, 2004, Pages 646-650

  Ashorn, Merja ^a,f   Rägö, Tiina ^a   Kokkonen, Jorma ^c   Ruuska, Tarja ^b   Rautelin, Hilpi ^d   Karikoski, Riitta ^e  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b Tartu University Children's Hospital   (Estonia)

^c OULU UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^f TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Eradication; Helicobacter pylori; Symptoms; Treatment

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE; PLACEBO;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; BIOPSY TECHNIQUE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DYSPEPSIA; ENDOSCOPIC SURGERY; ENDOSCOPY; ERADICATION THERAPY; FEMALE; FOLLOW UP; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; INFECTION; INFLAMMATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SCHOOL CHILD; SYMPTOMATOLOGY; UREA BREATH TEST;

ABDOMINAL PAIN; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CHILD; CLARITHROMYCIN; DOUBLE-BLIND METHOD; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; OMEPRAZOLE; PROSPECTIVE STUDIES; RECURRENCE; TIME FACTORS;

EID: 4143139689     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000135366.58536.b3     Document Type: Article

References (18)

1. Bode G, Rothenbacher D, Brenner H, et al. Helicobacter pylori and abdominal symptoms: a population-based study among preschool children in southern Germany. Pediatrics. 1998;101:634-637.
2. Shashidhar H, Peters J, Lin CH, et al. A prospective trial of lansoprazole triple therapy for pediatric Helicobacter pylori infection. J Pediatr Gastroenterol Nutr. 2000;30:276-282.
3. Talley NJ, Vakil N, Ballard ED, et al. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. N Engl J Med. 1999;341:1106-1111.
4. Oderda G, Rapa A, Bona G. A systematic review of Helicobacter pylori eradication treatment schedules in children. Aliment Pharmacol Ther. 2000;14(suppl. 3):59-66.
5. Frank F, Stricker T, Stallmach T, et al. Helicobacter pylori infection in recurrent abdominal pain. J Pediatr Gastroenterol Nutr. 2000;31:424-427.
6. Uc A, Chong SK. Treatment of Helicobacter pylori gastritis improves dyspeptic symptoms in children. J Pediatr Gastroenterol Nutr. 2002;34: 281-285.
7. Sherman P, Czinn S, Drumm B, et al. Helicobacter pylori infection in children and adolescents: Working group report of the first world congress of pediatric gastroenterology, hepatology, and nutrition. J Pediatr Gastroenterol Nutr. 2002;35(suppl. 2):128-133.
8. Rasquin-Weber A, Hyman PE, Cucchiara S, et al. Childhood functional gastrointestinal disorders. Gut. 1999;45(suppl. II):II60-II68.
9. Talley NJ, Phillips SF, Wiltgren CM, et al. Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc. 1990;65:1456-1479.
10. Dimenäs E, Carlsson G, Glise H, et al. Relevance of norm values as part of documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol. 1996;31:8-13.
11. Gottrand F, Kalach N, Spyckerelle C, et al. Omeprazole combined with amoxycillin and clarithromycin in the eradication of Helicobacter pylori in children with gastritis: a prospective randomized double blind trial. J Pediatr. 2001;139:664-668.
12. Talley NJ, Lauritsen K. The potential role of acid suppression in functional dyspepsia: the BOND, OPERA, PILOT, and ENCORE studies. Gut. 2002;50(suppl. 4):36-41.
13. Blum AL, Talley NJ, O'Morain C, et al. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia: Omeprazole plus clarithromycin and amoxicillin effect one year after treatment (OCAY) Study Group. N Engl J Med. 1998;339:1875.
14. Froehlich F, Gonvers JJ, Wietlisbach V, et al. Helicobacter pylori eradication does not benefit patients with nonulcer dyspepsia. Am J Gastroenterol. 2001;96:2329-2336.
15. Laine L, Schoenfeld P, Fennerty MB. Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials. Ann Intern Med. 2001;134:361-369.
16. Verma S, Giaffer MH. Helicobacter pylori eradication ameliorates symptoms and improves quality of life in patients on long-term acid suppression. A large prospective study in primary care. Dig Dis Sci. 2002;47: 1567-1574.
17. Imrie C, Rowland M, Bourke B, et al. Is Helicobacter pylori infection in childhood a risk factor for gastric cancer? Pediatrics. 2001;107:373-380.
18. Ashorn M, Ruuska T, Mäkipernaa A. Helicobacter pylori infection and iron deficiency anemia in children. Scand J Gastroenterol. 2001;36:701-705.